Xu Mei - China Health CEO and President and Director
CNHC Stock | USD 0.01 0 31.67% |
CEO
Xu Mei is CEO and President and Director of China Health Management
Phone | 214-691-0055 |
Web | https://www.chinahealthcorp.com |
Similar Executives
Found 3 records | CEO Age | ||
Murray Fleming | Glucose Health | 60 | |
Dean Connor | Sun Life Financial | 63 | |
Nhon Luc | Sun Life Financial | N/A |
China Health Management Leadership Team
Elected by the shareholders, the China Health's board of directors comprises two types of representatives: China Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Health's management team and ensure that shareholders' interests are well served. China Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Leslie Crone, CFO and Secretary | ||
Robert Kuhnemund, Chairman of the Board, CEO | ||
M Shu, Head Nurse of Patient Care Services Department | ||
Charles Chen, Chief Medical Officer of Medical Department | ||
Xu Mei, CEO and President and Director | ||
Brian Norman, Director | ||
Gary Raabe, Chief Technical Officer | ||
Ni Shu, Head Department | ||
Liang Xu, Head of Fin. and Accounting and Admin. Director | ||
Lawrence Cahill, Director | ||
Rui Qu, Department Head of Physical Examination Department | ||
Gwynda Gee, Vice President of Operations | ||
Mary McAlpine, President |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Profit Margin | (0.24) % | |||
Operating Margin | (0.21) % | |||
Current Valuation | 17.53 M | |||
Shares Outstanding | 81.15 M | |||
Price To Earning | (1.80) X | |||
Price To Sales | 3.18 X | |||
Revenue | 542.38 K | |||
Gross Profit | 108.47 K | |||
Net Income | (129.28 K) | |||
Current Ratio | 1.09 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Health's short interest history, or implied volatility extrapolated from China Health options trading.
Pair Trading with China Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Health will appreciate offsetting losses from the drop in the long position's value.Moving against China Pink Sheet
0.61 | AA | Alcoa Corp Fiscal Quarter End 31st of March 2024 | PairCorr |
0.57 | HPQ | HP Inc Financial Report 4th of June 2024 | PairCorr |
0.46 | BA | Boeing Fiscal Quarter End 31st of March 2024 | PairCorr |
0.46 | DD | Dupont De Nemours Fiscal Quarter End 31st of March 2024 | PairCorr |
0.44 | PTAIY | Astra International Tbk | PairCorr |
The ability to find closely correlated positions to China Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace China Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back China Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling China Health Management to buy it.
The correlation of China Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as China Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if China Health Management moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for China Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Health Management. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the China Health Management information on this page should be used as a complementary analysis to other China Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for China Pink Sheet analysis
When running China Health's price analysis, check to measure China Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Health is operating at the current time. Most of China Health's value examination focuses on studying past and present price action to predict the probability of China Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Health's price. Additionally, you may evaluate how the addition of China Health to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |